Clinical Trial Update: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial investigating carboplatin, paclitaxel, and pegfilgrastim in patients with Stage III/IV ovarian epithelial, fallopian tube, primary peritoneal, or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Ovarian Carcinosarcoma
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Carcinoma, Infectious Disorder | Phase 1 | Status: COMPLETED